1 EXHIBIT 11.1 NUTRACEUTIX, INC. COMPUTATION OF EARNINGS (LOSS) PER SHARE Three months ended Nine months ended September 30, September 30, ----------------------------------- ----------------------------------- 2000 1999 2000 1999 ------------ ------------ ------------ ------------ PRIMARY AND FULLY DILUTED: Weighted average shares 17,698,588 17,489,812 17,563,589 17,299,794 outstanding Effect of dilutive stock 1,728,479 2,105,832 1,728,479 -- equivalents Effect of shares over market (1,141,800) (1,262,066) (1,141,800) -- ------------ ------------ ------------ ------------ Total 18,285,267 18,333,578 18,150,268 17,299,794 Net earnings (loss) $ 442,035 $ 244,900 $ 98,894 $ (33,591) ============ ============ ============ ============ Primary net earnings (loss) per $ 0.025 $ 0.014 $ 0.006 $ (0.002) share ============ ============ ============ ============ Fully diluted net earnings (loss) per share $ 0.024 $ 0.013 $ 0.005 $ (0.002) ============ ============ ============ ============ 22